Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Cognitive Dysfunction in Multiple Sclerosis (1)

Cognitive Dysfunction in Multiple Sclerosis (1)

Tuesday, June 21, 2011

The New York Academy of Sciences

Presented By

Presented by The New York Academy of Sciences


In less than two decades remarkable advances have been made in the therapeutics of MS, particularly in the development of disease-modifying treatments for relapsing forms of the disease. From no treatment available prior to 1993, the therapeutic armamentarium has expanded to include 8 FDA-approved agents currently marketed in the US. Many other drugs and biologicals are in advanced stages of clinical development, with several having reported successful results in Phase III trials. These have novel mechanisms of action and more desirable routes or frequency of administration than the injectable drugs that have been the mainstay of MS therapy in the 1990s and the first decade of the 21st century. These advances will make the treatment of MS more effective, but also more challenging and complex as MS specialists seek to optimize treatment on an individual basis. While therapeutic activity for relapsing MS has perhaps exceeded that in all of neurology during the past two decades, nonetheless the lack of effective therapy for progressive forms of MS remains a major disappointment. This talk will highlight the currently marketed drugs, describe the new therapeutic agents nearing possible FDA approval, and review the issues that continue to confront investigators in the field.

Reception to follow.

Keynote Speaker

Aaron E. Miller, MD

Mount Sinai School of Medicine


Jeffery N. Gingold

MS Patient Advocate

Nicholas G. LaRocca, PhD

National Multiple Sclerosis Society

Cynthia Sitcov

MS Patient Advocate

Registration Pricing

Student Member:$15
Student Nonmember:$20


Presented by

Gold Sponsors

For a full list of sponsors, please visit the Sponsors tab.


*Presentation times are subject to change.

5:00 PM


5:30 PM

Welcome Remarks
Sonya Dougal. PhD, The New York Academy of Sciences

5:45 PM

Keynote Address
State of the Science in Therapeutics for Multiple Scelrosis
Aaron E. Miller, MD, Mount Sinai School of Medicine

6:30 PM

Panel Discussion

- Jeffrey N. Gingold, MS Patient Advocate
- Nicholas G. LaRocca, PhD, National Multiple Sclerosis Society
- Cynthia Sitcov, MS Patient Advocate

Aaron E. Miller, MD, Mount Sinai School of Medicine

7:30 PM

Networking Reception

Travel & Lodging

Our Location

The New York Academy of Sciences

7 World Trade Center
250 Greenwich Street, 40th floor
New York, NY 10007-2157

Click here for directions.

Hotels Near 7 World Trade Center

Recommended partner hotel:


The New York Academy of Sciences is a part of the Club Quarters network. Please feel free to make accommodations with Club Quarters on-line to save significantly on hotel costs.

Club Quarters Reservation Password: NYAS

Club Quarters, World Trade Center
140 Washington Street
New York, NY 10006
Phone: (212) 577-1133

Located on the south side of the World Trade Center, opposite Memorial Plaza, Club Quarters, 140 Washington Street, is just a short walk to our location.

Other hotels located near 7 WTC:

Millenium Hilton


Marriott Financial Center


Club Quarters, Wall Street


Eurostars Wall Street Hotel


Wall Street District Hotel


Wall Street Inn


Ritz-Carlton New York, Battery Park


Special Needs and Additional Information

For any additional information and for special needs, including child/family care resources available to conference attendees, please e-mail or call Crystal Ocampo 212.298.8632.